MedPath
NMPA Approval

Ceftazidime and Avibactam Sodium for Injection

国药准字H20249571

December 1, 2024

Drug Information

注射用头孢他啶阿维巴坦钠

注射剂

2.5g(C₂₂H₂₂N₆O₇S₂ 2.0g与C₇H₁₁N₃O₆S 0.5g)

化学药品

December 1, 2024

Company Information

Applicant Company

海口市南海大道281号

Manufacturing Company

海南省海口市秀英区南海大道192号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢他啶阿维巴坦钠 - NMPA 批准文号 | MedPath